(2-(4-(6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]selenophene-3-carbonyl)phenoxy)ethyl)methyloctylamine hydrochloride

ID: ALA3343813

PubChem CID: 118717355

Max Phase: Preclinical

Molecular Formula: C32H38ClNO4Se

Molecular Weight: 578.61

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCCCCCCCN(C)CCOc1ccc(C(=O)c2c(-c3ccc(O)cc3)[se]c3cc(O)ccc23)cc1.Cl

Standard InChI:  InChI=1S/C32H37NO4Se.ClH/c1-3-4-5-6-7-8-19-33(2)20-21-37-27-16-11-23(12-17-27)31(36)30-28-18-15-26(35)22-29(28)38-32(30)24-9-13-25(34)14-10-24;/h9-18,22,34-35H,3-8,19-21H2,1-2H3;1H

Standard InChI Key:  UWLHJCSVNKXXOC-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 39 41  0  0  0  0  0  0  0  0999 V2000
   21.1905   -8.9783    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   14.6750  -11.1476    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6739  -11.9671    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3819  -12.3761    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3801  -10.7387    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0887  -11.1440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0890  -11.9672    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8720  -12.2214    0.0000 Se  0  0  0  0  0  2  0  0  0  0  0  0
   17.3557  -11.5552    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8716  -10.8895    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1696  -11.5535    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5779  -12.2627    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3943  -12.2628    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8035  -11.5544    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3902  -10.8445    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5752  -10.8479    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9658  -12.3752    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.1238  -10.1122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9231   -9.9420    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.5768   -9.5051    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8338   -8.7283    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2876   -8.1215    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4874   -8.2914    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2363   -9.0735    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7842   -9.6769    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9395   -7.6850    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.1405   -7.8562    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5927   -7.2498    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7936   -7.4211    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.6207  -11.5530    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.2458   -6.8147    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5424   -8.1987    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7433   -8.3699    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4921   -9.1475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6930   -9.3187    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4418  -10.0964    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6427  -10.2676    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3915  -11.0452    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5925  -11.2164    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  2  0
  3  4  1  0
  4  7  2  0
  6  5  2  0
  5  2  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10  6  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
  9 11  1  0
  3 17  1  0
 10 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
 23 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 14 30  1  0
 29 31  1  0
 29 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
 35 36  1  0
 36 37  1  0
 37 38  1  0
 38 39  1  0
M  END

Associated Targets(Human)

MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

MG-22A (171 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 578.61Molecular Weight (Monoisotopic): 579.1888AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Arsenyan P, Paegle E, Domracheva I, Gulbe A, Kanepe-Lapsa I, Shestakova I..  (2014)  Selenium analogues of raloxifene as promising antiproliferative agents in treatment of breast cancer.,  87  [PMID:25282270] [10.1016/j.ejmech.2014.09.088]

Source